global-blood-therapeutics
Pfizer to Boost Pipeline With US$ 5,4 Billion Global Blood Therapeutics Buy

Pfizer to Boost Pipeline With US$ 5,4 Billion Global Blood Therapeutics Buy

Pfizer Inc looks to boost its pipeline to combat a potential slowdown in Covid product demand that analysts anticipate from falling cases.

Pfizer to Boost Pipeline With US$ 5,4 Billion Global Blood Therapeutics Buy
IHSG
7.053,15
0.39%
-27,37
LQ45
1.001,74
0.26%
-2,58
USD/IDR
15.647
-0,34
EMAS
981.000
0,10%